Volume 15, Number 10—October 2009
Lack of Airborne Transmission during Outbreak of Pandemic (H1N1) 2009 among Tour Group Members, China, June 2009
During June 2–8, 2009, an outbreak of influenza A pandemic (H1N1) 2009 occurred among 31 members of a tour group in China. To identify the mode of transmission and risk factors, we conducted a retrospective cohort investigation. The index case-patient was a female tourist from the United States. Secondary cases developed in 9 (30%) tour group members who had talked with the index case-patient and in 1 airline passenger (not a tour group member) who had sat within 2 rows of her. None of the 14 tour group members who had not talked with the index case-patient became ill. This outbreak was apparently caused by droplet transmission during coughing or talking. That airborne transmission was not a factor is supported by lack of secondary cases among fellow bus and air travelers. Our findings highlight the need to prevent transmission by droplets and fomites during a pandemic.
Since the emergence of a novel influenza A (H1N1) virus (later called influenza A pandemic [H1N1] 2009 virus) in early 2009 in Mexico (1,2), the virus has spread to 156 countries, territories, and areas; as of July 27, 2009, a total of 134,503 laboratory-confirmed cases and 816 deaths had been reported (3). On June 11, 2009, the World Health Organization declared that the world was experiencing the start of the 2009 influenza pandemic (4). Investigations of transmission chains early in the pandemic will add to our understanding of the special characteristics of this new virus, including whether its mode of transmission differs from that of seasonal influenza viruses. This information will be useful for effective control of the spread of this virus.
In the People’s Republic of China, the early response strategy has been containment, which includes temperature screening and administration of health questionnaires at international ports of entry, isolation of infected travelers, and quarantine of close contacts of infected persons. During June 2–8, 2009, an outbreak of pandemic (H1N1) 2009 occurred among members of a tour group. We investigated this outbreak to identify the source of infection, mode of transmission, and risk factors for infection.
The index case-patient was a 40-year-old female US citizen who had traveled from the United States to Jiuzhaigou, a popular tourist spot in southwestern China; she stopped to change planes in Hong Kong and Chengdu. She noticed her first symptom, chills, on June 2, immediately before arriving in Chengdu, ≈23 hours after departure from the United States. After learning that she had traveled on 3 flights and had toured with a group, we obtained the manifests of all flights that she had traveled on and asked all passengers of the 3 flights and all members of the tour group by telephone or in-person interview whether they had had any symptoms from May 27 through June 12, 2009. We also obtained detailed information on the activities of the tour group during the 3-day tour. Health authorities placed members of the tour group under medical observation and isolated those who had clinical signs or symptoms or positive throat swab culture results. Laboratory technicians at the Sichuan Province Center for Disease Control and Prevention collected throat swabs every 24 hours from all members of the tour group and from symptomatic persons who had shared any of the 3 flights with the index case-patient. Real-time reverse transcription–PCR (RT-PCR) was performed to detect nucleic acids specific for the influenza A pandemic (H1N1) 2009 virus by using the primers supplied by the World Health Organization.
We defined a suspected case as onset of >1 of 5 symptoms—fever (>38°C), cough, sore throat, chills, or headache—in a passenger of flight CZ6659 (June 3, Chengdu to Jiuzhaigou) or flight CZ6660 (June 5, Jiuzhaigou to Chengdu) or in a member of the tour group. A confirmed case was a suspected case for which real-time RT-PCR provided laboratory confirmation of the influenza A pandemic (H1N1) 2009 virus infection. A secondary case was a confirmed case for which the patient’s signs or symptoms began after 9:00
To identify the mode of transmission and risk factors for infection, we conducted a retrospective cohort investigation. We interviewed all members of the tour group by telephone or in-person interview to ascertain details of their contact history with the index case-patient.
During this outbreak, we identified a total of 11 confirmed cases of influenza A pandemic (H1N1) 2009 infection (Figure 1). Average patient age was 36 (range 18–59) years; 2 patients were men and 9 were women. Signs and symptoms were cough (73%), fever (64%), sore throat (64%), headache (27%), chills (27%), runny nose (18%), and myalgia (18%). All 11 case-patients fully recovered; 3 (including the index case-patient) recovered on June 13, 5 on June 15, 1 on June 17, and 2 on June 18. The mean duration of illness was 11 (range 9–14) days.
The index case-patient left New York City, United States, on flight CX841 at 12:00
All airplanes boarded by the index case-patient had high-efficiency particulate air filters. Less than half of the air in the passenger cabins was recirculated; the rest was from outside. Air in the passenger cabins of the airplanes was recirculated approximately every 3 minutes. The air conditioning system in the tour bus mixed ≈70% recirculated inside air with ≈30% outside air, filtered it, and delivered it into the bus through air outlets above the passenger seats. A vent at the back of the bus continually exhausted air from inside the bus.
The diagnosis of influenza A pandemic (H1N1) 2009 virus infection was made for the index case-patient after she returned to Chengdu on June 5. Subsequently, members of the tour group were placed under involuntary medical observation. No influenza-like illness developed in any of the 91 passengers of flight CA428 (Hong Kong to Chengdu) or in any of the 87 passengers on flight CZ6659 (Chengdu to Jiuzhaigou) who were not members of the tour group. None of the passengers on either flight had donned a mask. However, excluding the index case-patient, 9 (30%) of the 30 members of the tour group became ill with secondary cases of disease. The secondary attack rate did not differ between the members of the tour group who flew from Chengdu to Jiuzhaigou and the members who joined the tour in Jiuzhaigou. Of the 87 passengers on the return flight (Jiuzhaigou to Chengdu) on June 5 who were not members of the tour group, 1 person became ill (Table 1). Her seat (9A) was within 2 rows of seats of the index case-patient (7A) and a secondary case-patient (7B), each of whom was symptomatic during the return flight from Jiuzhaigou to Chengdu on June 5.
Among members of the tour group, the attack rate was higher for women (50%) than for men (13%) (2-tailed Fisher exact test, p = 0.05). The secondary attack rate among persons 18–39 years of age was 41% (7/17; exact 95% confidence interval [CI] 18–67) compared with 21% (3/14; exact 95% CI 4.7–51) for persons 40–63 years of age.
The index case-patient began having chills at ≈9:00
Since its emergence, pandemic (H1N1) 2009 has spread around the world, including 1,930 confirmed cases in China as of July 27, 2009 (5). Of the cases that have occurred in China (excluding Hong Kong, Macao, and Taiwan), >80% have been imported (6); however, several outbreaks caused by transmission from imported case-patients have also occurred in China. Our investigation documented 1 such outbreak.
Seasonal influenza A is transmitted directly by large droplets, or indirectly by fomites (7). However, the transmission dynamics of the influenza A pandemic (H1N1) 2009 virus have been less well researched. Our data show that this outbreak was caused by talking with the index case-patient at close range, which indicates droplet transmission. Conversely, other kinds of contact, such as dining at the same table and receiving chewing gum from the index case-patient, played no role during this outbreak.
The role of airborne transmission for influenza is debatable (7–10). Our investigation did not find evidence of airborne transmission during this outbreak. The lack of cases among 14 tourists who were with the index case-patient in an enclosed bus cabin for nearly 7 hours suggests that airborne transmission was not a factor. The absence of secondary cases among passengers of the flight from Chengdu to Jiuzhaigou also supports this conclusion. Although the case-patient with disease onset on June 8 appeared to have been infected while sharing the flight from Jiuzhaigou to Chengdu, she sat within 2 seats of 2 symptomatic case-patients, which is also consistent with droplet or fomite transmission.
During this outbreak, the index case-patient was febrile while traveling on 3 flights. A secondary case-patient was also febrile while traveling on the return flight (Jiuzhaigou to Chengdu). Neither patient’s illness was detected by thermal scanning at the airports. Another secondary case-patient had had a headache during the return flight. The index case-patient filled out a health questionnaire but did not truthfully inform health authorities of her symptoms. The other 9 case-patients began having symptoms after returning home; hence, they were also not detected by airport screening. These data suggest that thermal scanning and health questionnaires at the airports were not effective for detecting pandemic (H1N1) 2009 infections.
The main limitation of our investigation was the possibility of recall bias; i.e., those who became ill might have more accurately recalled their contact history than those who did not. However, the index case-patient had a highly distinctive hairstyle, which made her easy to remember. Also, interviews about the tourists’ exposure to the index case-patient were conducted within 1 week of the completion of their tour. These 2 factors should have helped minimize any potential recall bias.
In conclusion, this outbreak of influenza A pandemic (H1N1) 2009 virus infection was caused by transmission during coughing or vocalization by an imported case-patient. The virus spread by droplet transmission when the index case-patient was talking with her fellow tourists. The findings of our investigation highlight the importance of preventing droplet transmission during a pandemic.
Mr Han is an officer (8th cohort) of the Chinese Field Epidemiology Training Program. His research interest is prevention and control of acute infectious diseases.
We are indebted to Robert Fontaine for his guidance during the outbreak investigation and for his comments and suggestions on data analysis and manuscript preparation. We also thank Jeffery McFarland for his helpful comments on the manuscript.
- Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15.
- Ginocchio CC, St George K. Likelihood that an unsubtypeable influenza A result in the Luminex xTAG Respiratory Virus Panel is indicative of novel A/H1N1 (swine-like) influenza. J Clin Microbiol. 2009; [Epub ahead of print]
- World Health Organization. Pandemic (H1N1)—update 59: laboratory-confirmed cases of new influenza A(H1N1) as officially reported to WHO by States Parties to the IHR (2005). 2009 [cited 2009 Jul 27]. Available from http://www.who.int/csr/don/2009_07_27/en/index.html
- World Health Organization. World now at the start of 2009 influenza pandemic. 2009 [cited 2009 Jun 19]. Available from http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html
- Chinese Ministry of Health. Information on prevention and control of novel influenza A (H1N1) virus. 2009 [in Chinese] [cited 2009 Jun 27]. Available from http://220.127.116.11/publicfiles/business/htmlfiles/mohbgt/s3582/200907/41941.htm
- Chinese Center for Disease Control and Prevention. Health topics. Novel influenza A (H1N1) epidemic reports. 2009 [cited 2009 Jun 26]. Available from http://www.chinacdc.net.cn/n272442/n272530/n273736/n273781/n4624704/n4624712/31868.html
- Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257–65.
- Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol. 1979;110:1–6.
- Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis. 2006;12:1657–62.
- Lemieux C, Brankston G, Gitterman L, Hirji Z, Gardam M. Questioning aerosol transmission of influenza. Emerg Infect Dis. 2007;13:173–4.
- Figure 1. Time of disease onset for persons infected with influenza A pandemic (H1N1) 2009 virus, Sichuan Province, China, June 2009.
- Figure 2. Timeline of exposures to the index case-patient during outbreak of influenza A pandemic (H1N1) 2009, Sichuan Province, China, June 2009. Numbers in parentheses indicate number of persons exposed.
- Table 1. Secondary attack rate for influenza A pandemic (H1N1) 2009, by travel history, Sichuan Province, China, June 2009
- Table 2. Secondary attack rate of influenza A pandemic (H1N1) 2009 among the tour group members, by exposure, Sichuan Province, China, June 2009
Suggested citation for this article: Han K, Zhu X, He F, Liu L, Zhang L, Ma H, et al. Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009. Emerg Infect Dis [serial on the Internet]. 2009 Oct [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/10/09-1013
Please use the form below to submit correspondence to the authors or contact them at the following address:
Guang Zeng, Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, 27 Nanwei Rd, Xuanwu District, Beijing 100050, People’s Republic of China
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 08, 2010
- Page last updated: December 08, 2010
- Page last reviewed: December 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)